United Kingdom Model for End-Stage Liver Disease (UKELD)

ورودی‌های بالینی بیمار

حداقل ۰.۸ — حداکثر ۱۰ • واحد: ratio

حداقل ۳۰ — حداکثر ۸۰۰ • واحد: µmol/L

حداقل ۵ — حداکثر ۱۰۰۰ • واحد: µmol/L

حداقل ۱۲۰ — حداکثر ۱۵۰ • واحد: mmol/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
ukeld score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Below Transplant Threshold0–48
  • Transplant Eligible49–59
  • High Priority Transplant60–100
Direct Clinical Answer

The United Kingdom Model for End-Stage Liver Disease (UKELD) calculates predicting mortality in end-stage liver disease patients for liver transplant planning. Key inputs include inr. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts mortality in end-stage liver disease patients for liver transplant planning. Developed specifically for UK population to determine eligibility for liver transplantation and estimate patient prognosis.

Clinical Indication

The United Kingdom Model for End-Stage Liver Disease (UKELD) is indicated for bedside clinical practice to support Predicts mortality in end-stage liver disease patients for liver transplant planning. Developed specifically for UK population to determine eligibility for liver transplantation and estimate patient prognosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Excludes patients with hepatocellular carcinoma, who may qualify for transplantation through other criteria.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.

Formula & Variables:

UKELD Score = 5.395 × ln(INR) + 1.485 × ln(creatinine, µmol/L) + 3.13 × ln(bilirubin, µmol/L) - 81.565 × ln(sodium, mmol/L) + 435

Input Parameters

NameTypeRequiredDescription
inrfloatYesInternational Normalized Ratio (INR) - measure of blood clotting time(ratio)
creatinine_umol_lfloatYesSerum creatinine concentration in micromoles per liter(µmol/L)
bilirubin_umol_lfloatYesSerum bilirubin concentration in micromoles per liter(µmol/L)
sodium_mmol_lfloatYesSerum sodium concentration in millimoles per liter(mmol/L)

Score Interpretation & Guidance

RangeStageDescription
0–48Below Transplant ThresholdLow mortality risk
49–59Transplant EligibleModerate to high mortality risk
60–100High Priority TransplantVery high mortality risk

Evidence-Based References (EBM)

  • Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, Hudson M. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut. 2008;57(2):252-7.
  • Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation. 2011;92(4):469-76.

Related calculators